Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_1388:p2
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 1388 (pt 2/2)
Character Range: 658434–659352

than 25% and the nominal capacity of the container is no more than 15 millilitres, the medicine must have a restricted flow insert fitted on the container.
                                                                                                                                                     When for internal use then the concentration of safrole in a medicine must be no more than 0.1%.
                                                                                                                                                     When for uses other than internal use, the concentration of safrole in a medicine must be no more than 1.0%.
                                                                                                                                                     When used as an active ingredient, the concentration of coumarin in the medicine must be no more than 0.001%.